Form 13-F position report

GILEAD SCIENCES INC

Reported by AUGUSTINE ASSET MANAGEMENT INC

GILD CUSIP 375558103 Manager CIK 0000778963

Reported 52,817 shares, down 1,185 (2.2%) from the prior quarter.

Reported value 36.1%; share count -2.2% vs. the prior quarter.

Reduced
% of reported 13F value 2.51% This manager · Q4 2022
Shares 52,817 Quarter-end amount reported
Reported value $4,534,350 Fair value at quarter end
Consecutive quarters held 22 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 4095000
2022-03-31 3359000
2022-06-30 3214000
2022-09-30 3331000
2022-12-31 4534350
2023-03-31 4353880
2023-06-30 4045070
2023-09-30 3828685
2023-12-31 4309754
2024-03-31 3863372
2024-06-30 3637241
2024-09-30 4467187
2024-12-31 4789042
2025-03-31 5460545
2025-06-30 5465111
2025-09-30 5452185
2025-12-31 6005887
2026-03-31 6819861
2026-06-30 6125531
2026-09-30 7189351

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by AUGUSTINE ASSET MANAGEMENT INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 48,234 -250 (-0.5%) 1.55% $7,189,351 2026-10-13
Q2 2026 Reduced 48,484 -449 (-0.9%) 1.24% $6,125,531 2026-07-13
Q1 2026 Added 48,933 +1 (0.0%) 1.54% $6,819,861 2026-04-13
Q4 2025 Reduced 48,932 -187 (-0.4%) 1.2% $6,005,887 2026-01-16
Q3 2025 Reduced 49,119 -174 (-0.4%) 1.1% $5,452,185 2025-10-22
Q2 2025 Added 49,293 +560 (1.1%) 1.46% $5,465,111 2025-07-16
Q1 2025 Reduced 48,733 -3,113 (-6.0%) 1.6% $5,460,545 2025-04-25
Q4 2024 Reduced 51,846 -1,436 (-2.7%) 1.26% $4,789,042 2025-01-29
Q3 2024 Added 53,282 +269 (0.5%) 1.56% $4,467,187 2024-10-25
Q2 2024 Added 53,013 +271 (0.5%) 1.4% $3,637,241 2024-08-01
Q1 2024 Reduced 52,742 -458 (-0.9%) 1.61% $3,863,372 2024-04-26
Q4 2023 Added 53,200 +2,110 (4.1%) 1.91% $4,309,754 2024-01-24
Q3 2023 Reduced 51,090 -1,396 (-2.7%) 1.77% $3,828,685 2023-11-14
Q2 2023 Added 52,486 +11 (0.0%) 1.87% $4,045,070 2023-07-24
Q1 2023 Reduced 52,475 -342 (-0.6%) 2.16% $4,353,880 2023-05-01
Q4 2022 Reduced 52,817 -1,185 (-2.2%) 2.51% $4,534,350 2023-02-09
Q3 2022 Added 54,002 +2,011 (3.9%) 2.19% $3,331,000 2022-10-24
Q2 2022 Reduced 51,991 -4,519 (-8.0%) 1.97% $3,214,000 2022-08-02
Q1 2022 Added 56,510 +106 (0.2%) 1.69% $3,359,000 2022-04-27
Q4 2021 Reduced 56,404 -107 (-0.2%) 2.01% $4,095,000 2022-02-01
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1865 managers reported GILEAD SCIENCES INC for Q4 2022.

Managers reporting GILEAD SCIENCES INC in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 131,560,250 +3,099,517 0.35% $11,294,447,492 39 qtrs
VANGUARD GROUP INC Reduced 112,038,324 -48,947 0.26% $9,618,490,115 39 qtrs
Capital World Investors Added 68,892,972 +11,130,228 1.26% $5,914,384,895 39 qtrs
STATE STREET CORPORATION Reduced 58,941,373 -298,977 0.3% $5,060,116,872 39 qtrs
Capital Research Global Investors Added 54,602,952 +727,482 1.42% $4,687,661,581 39 qtrs
Dodge & Cox Reduced 35,885,152 -484,100 2.11% $3,080,740,299 34 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 23,848,477 +244,886 0.29% $2,044,282,000 39 qtrs
MORGAN STANLEY Added 17,196,950 +1,780,489 0.17% $1,476,358,401 39 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 16,545,609 +1,124,173 0.32% $1,420,440,534 39 qtrs
FMR LLC Added 16,438,903 +13,498,403 0.14% $1,411,279,810 39 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 09, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
52,817
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.